Why Is My Crohn's Worse on My Period?

Yes, this is a real and documented pattern, and no, you are not imagining it or being dramatic. Women with Crohn's disease report more diarrhoea and abdominal pain in the days before and during a period than women without it, and they have been reporting it in the research literature since at least 1998 (Kane 1998).

But there is a second half to the answer that almost no page covers, and it is the half that decides what you should actually do about it. The strongest evidence that your period changes your Crohn's is evidence about symptoms. The evidence that it changes your inflammation is much thinner, and the one prospective study that tracked women day by day through their cycles found that general gut symptoms fluctuated while IBD-specific disease activity did not change significantly (Lim 2013).

That distinction is not academic. It is the difference between "this is a rough week that will pass" and "my treatment is failing", and getting it wrong in either direction costs you something.

The short answer: two separate things are happening at once

The first thing is not about Crohn's at all. Cyclical bowel changes happen to a large share of people who menstruate. Prostaglandins released as the womb lining breaks down act on smooth muscle, and intestinal smooth muscle is not excluded from that. Our sister post on why IBS gets worse on your period works through that mechanism and the phase-by-phase hormone picture in detail, so this article will not rebuild it.

The second thing is what Crohn's adds. You are applying an ordinary monthly signal to a gut that is not ordinary: it may have active inflammation, or scarring from old inflammation, or a shortened small bowel after a resection, or a rectum that has already lost some of its capacity to hold on. The same nudge produces a bigger result.

Put those together and the honest answer to "why is my Crohn's worse on my period" is usually: your period is not doing anything unique to your Crohn's, it is doing the normal thing to a gut with less margin.

That framing is not a dismissal. It changes what helps. If the monthly worsening is a symptom-load effect, then planning around it, protecting your sleep, and having a pain plan that does not involve drugs your gut dislikes are reasonable moves. If it is your disease activity climbing, then planning around it is exactly the wrong response, and the only way to know is to look at what happens in the weeks either side.

What the studies actually measured, and what they did not

Most pages ranking for this question quote a single statistic, usually "over half of women with IBD report worse symptoms during menses", and stop there. That number is real, but it comes from a self-reported online survey, and the studies around it disagree with each other in ways that matter.

Here is the whole small literature, laid out honestly.

Read that table as a whole and a pattern emerges. Every study that asked women what they experience found a cyclical effect. The two studies that also measured something objective, a daily prospective diary in one case and endoscopic scores in the other, did not find the cycle moving Crohn's disease activity.

Two honest caveats about that table. The prospective study was small, 47 people with IBD, and used symptom reporting rather than biomarkers for its IBD measure, so it was not well powered to detect a modest inflammation effect. The endoscopy study was 75 women at a single clinic and compared scores taken at one point against menstrual distress reported at another. Neither is a definitive null. They are the best that exists, and the best that exists does not show your period driving inflammation.

Why a Crohn's gut reacts more to the same monthly signal

The mechanism question has two parts: what hormones do to any gut, and what Crohn's changes about the gut they are acting on.

Reviews of this area describe the first part as a combination of prostaglandin effects on smooth muscle around the start of bleeding and hormone-driven changes in transit and visceral perception across the cycle, with the evidence on transit direction genuinely inconsistent between studies (Bharadwaj 2015, Gastroenterology Report). A companion review by the same group notes that the picture is further complicated in IBD by the possibility that sex hormones influence the gut-brain-microbiota axis, which is stated as a hypothesis rather than a demonstrated mechanism (Bharadwaj 2015, Journal of Digestive Diseases).

The second part is where Crohn's actually differs, and it comes down to reserve.

• A lower symptom threshold to begin with. Around a third of people with IBD in clinical remission still meet criteria for IBS-type symptoms. A meta-analysis of 27 studies and 3,169 people put the pooled prevalence at 32.5% (Fairbrass 2020). If you already have a gut that reacts, a monthly prostaglandin surge lands on top of that, not on a blank slate.
• Less bowel to absorb the change. After an ileal or ileocaecal resection, transit and fluid handling are different, and the same speeding-up produces a looser result. The review of menstrual symptoms in IBD patients with and without surgery makes surgical status an explicit variable for exactly this reason (Bharadwaj 2015, Journal of Digestive Diseases).
• A rectum with less capacity. Urgency is a storage problem as much as a motility one. If disease or scarring has reduced rectal compliance, the extra stimulus arrives at a reservoir that is already close to its limit.
• Everything else that is already using up your reserve. Fatigue, poor sleep and pain sensitisation stack. Our post on stress, anxiety and Crohn's flares covers why a bad week can raise symptoms without raising inflammation, and a difficult period week is structurally the same story.

None of this requires your Crohn's to be doing anything new. It explains why identical hormonal weather produces a much rougher ride for you than for a colleague without the disease, which is the thing people in Crohn's forums keep trying to get across when they say it is "not just period poops".

Does your period raise your inflammation, or only your symptoms?

Here is where we have to be careful, because this is the question everyone actually wants answered, and the honest answer has a hole in the middle of it.

We could not find any study measuring faecal calprotectin across the menstrual cycle in people with IBD. Not one. We searched the literature for it this run and came up empty. If a page tells you your calprotectin rises on your period, ask it for the citation, because we could not find the study it would need.

There is, however, something worth knowing about blood tests. In the BioCycle Study, 259 healthy premenopausal women aged 18 to 44 were followed for up to two cycles with CRP and reproductive hormones measured up to eight times per cycle, timed with fertility monitors. CRP varied significantly across the cycle. More women were classified above the 3 mg/L cardiovascular risk threshold during menses than in other phases, 12.3% versus 7.4%. A ten-fold increase in estradiol was associated with a 24.3% decrease in CRP, and a ten-fold increase in luteal progesterone with a 19.4% increase. The authors concluded that CRP measurement should be standardised to menstrual cycle phase in reproductive-aged women (Gaskins 2012).

This matters more than it sounds. A borderline CRP taken on day two of your period, interpreted against a CRP taken mid-cycle three months earlier, is not a clean comparison, and neither you nor your clinician will usually know that. Writing the cycle day next to the result costs you ten seconds and gives your team context they otherwise do not have.

Faecal calprotectin has its own separate problem, which is that it varies a great deal day to day for reasons that have nothing to do with hormones. Our post on a high calprotectin with no symptoms covers the day-to-day variation, the first-morning sampling rule and what the number can and cannot tell you. One practical note that belongs here and not there: if you are collecting a stool sample during your period, take reasonable care to avoid menstrual blood contaminating it, and tell the lab or your team if you think it might have. We could not find a study quantifying what menstrual contamination does to a calprotectin result, so treat this as ordinary sampling hygiene rather than as a documented effect size.

"Is this blood from my period or my Crohn's?"

This is the question that comes up over and over in r/CrohnsDisease, and it is the one where the community is most openly frustrated. One thread, titled around exactly this ambiguity, drew more than fifty replies from people describing the same guessing game, including several who had assumed rectal bleeding was menstrual and later found it was not (r/CrohnsDisease thread). Someone else in the same thread described the opposite error, panicking about Crohn's bleeding that turned out to be a period arriving early.

There is no clever trick that settles this from the toilet bowl, and anyone who tells you there is has not had to do it. What you can do is gather the features that point one way or the other and hand the pattern, not the panic, to your team.

Features that point towards menstrual blood:

• It arrives with, and ends with, your bleeding days.
• It is in the water or on paper rather than mixed through the stool.
• Your bowel pattern otherwise looks like your normal baseline.
• You have the rest of your usual period picture with it.

Features that point towards gut bleeding, and towards contacting your team promptly:

• Blood mixed through the stool rather than sitting separately.
• Bleeding that starts before your period or continues after it finishes.
• Blood with mucus, urgency, or bowel movements waking you at night.
• A rising stool frequency in the same stretch.
• Dark or tarry stool at any point, which is a reason to seek same-day advice.

And the ones people forget: an anal fissure, haemorrhoids, and, in Crohn's specifically, a perianal fistula can all bleed, and none of them follow your cycle. The r/CrohnsDisease thread includes people describing exactly that discovery.

A practical habit that helps: log the bleeding and the cycle day in the same place, not in two apps. Over two or three cycles, a pattern that lines up exactly with your bleeding days and nothing else looks very different from bleeding that is creeping earlier each month, and that difference is information your gastroenterologist can act on. Our guide to building a symptom record a clinician will actually read covers how to present that without handing over forty pages.

"Is this cramp my uterus or my bowel?"

Honestly, often you cannot tell, and neither can a lot of clinicians without more information. The most upvoted reply in one r/CrohnsDisease period thread was a long, funny description of exactly this confusion, sitting on the toilet waiting to find out which organ was responsible (r/CrohnsDisease thread).

Some clues that help, none of which are diagnostic:

• Does opening your bowels change it? Pain that eases or changes after a bowel movement is more suggestive of a bowel origin.
• Where does it sit? Crohn's pain from the commonest disease site tends to be lower right, period pain is more often central and low, though both generalise when they are bad.
• Does it track your bleeding days exactly, every month? Tight cycle-locking points towards a gynaecological cause, including endometriosis.
• What is it like? Steady ache versus waves matters, and so does whether it builds after eating.

And then there is the one pattern that should never be filed under period pain.

The literature carries cases going both ways, which is a useful antidote to confidence in either direction. A woman who was referred with obstructing Crohn's disease on imaging turned out, on histology after resection, to have transmural bowel endometriosis (Popivanov 2020). Another woman, whose abdominal pain and fullness recurred monthly with her period and who was clinically diagnosed with intestinal endometriosis, turned out on histology after resection to have Crohn's disease with no endometrial tissue at all (Nakao 2000). These are single case reports, and they are worth exactly what case reports are worth, but they make the point that monthly timing alone does not establish which organ is generating the pain.

Our guide to telling whether you are actually in a Crohn's flare covers the other look-alikes that get mistaken for disease activity, including infection and bile acid malabsorption after ileal resection.

The painkiller trap nobody warns you about

This is the section that has the most direct chance of changing something, and it is the one the general "8 tips for periods with Crohn's" articles skate over.

The default over-the-counter answer for period pain is a non-steroidal anti-inflammatory drug. NSAIDs work well for dysmenorrhoea. They also have a specific and awkward relationship with inflammatory bowel disease.

In a study of 209 people with IBD, those with quiescent Crohn's or ulcerative colitis were given a non-NSAID analgesic or one of three conventional NSAIDs for four weeks. Non-selective NSAIDs were associated with a 17% to 28% relapse rate within nine days of starting, using the Harvey-Bradshaw Index to define relapse in Crohn's. No patient relapsed early on acetaminophen (paracetamol), on the selective COX-2 inhibitor nimesulide, or on low-dose aspirin, and the clinical relapses came with rising faecal calprotectin (Takeuchi 2006). The subgroups were small, roughly 20 to 30 people per arm, so treat the individual drug comparisons as indicative rather than settled.

A larger cohort study found the same direction of effect at a more realistic dose. Among 791 people with IBD in remission followed for six months, those with Crohn's who used NSAIDs five or more times a month had a higher risk of active disease at follow-up, 23% versus 15%, with an adjusted risk ratio of 1.65 (95% CI 1.12 to 2.44). In ulcerative colitis there was no such effect (Long 2016). That cohort was self-reported and internet-based, so exposure and outcome both rely on what participants entered.

It is also worth naming what a good version of that conversation sounds like, because "can I take ibuprofen" invites a yes or no and you want more than that. A better opening is: "My period pain is significant enough that I need something for two or three days a month. Given my Crohn's, what would you want me to use, and is there anything I should avoid?" Our post on questions to ask your doctor about Crohn's has more on framing questions so they cannot be answered with a single word.

The other monthly loss: iron

Crohn's and menstruation both take iron, and the combination is under-discussed.

Anaemia is common in Crohn's specifically, more so than in ulcerative colitis. In a Swedish population-based cohort, the incidence of anaemia was 19.3 per 100 person-years in Crohn's compared with 12.9 in ulcerative colitis, and the prevalence was 28.7% versus 16.5%. Stricturing disease in Crohn's was associated with an increased risk (hazard ratio 2.59), and Crohn's patients were less likely than ulcerative colitis patients to have their anaemia resolve within twelve months, 56% versus 75% (Eriksson 2018). Anaemia is also recognised as the most common extraintestinal manifestation of IBD in the European consensus on extraintestinal disease (Harbord 2016).

In a Polish series of 136 newly diagnosed patients, anaemia was present at diagnosis in 65.4%, and female patients were more often anaemic than male patients (Wozniak 2019). International guidelines on iron deficiency in IBD recommend screening rather than waiting for symptoms, and set out that iron deficiency and anaemia in IBD need specific evaluation rather than being treated as an incidental lab finding (Gasche 2007). That guideline is now old, and we did not read a conflict of interest statement for it, so treat it as establishing the principle of screening rather than as current practice detail.

Now add heavy periods to that. In an Italian IBD clinic cohort of 82 women selected because they had at least one symptom compatible with endometriosis, heavy menstrual bleeding was reported by 60.9% (Neri 2026). That is a selected population and not a prevalence estimate for everyone with IBD, but it is a reminder that heavy bleeding is common enough in this group to be worth asking about.

The practical consequence is simple and often missed. If you feel wiped out in the week of and the week after your period, that is not automatically your Crohn's. Iron deficiency causes fatigue, breathlessness on exertion, poor concentration and reduced exercise tolerance, and it does so before haemoglobin falls far enough to be called anaemia.

Endometriosis: the diagnosis a Crohn's label can hide

This is the single most important thing in this article, because it is the one where a missed answer costs years.

If you already have Crohn's, you have a ready-made explanation for pelvic pain, and so does everyone who examines you. That is exactly the situation in which a second condition goes unnoticed. Multiple people in the Crohn's threads describe being told their pain was Crohn's for years before an endometriosis diagnosis, including one who described a large ovarian endometrioma being found only when it became impossible to ignore (r/CrohnsDisease thread).

The research supports taking this seriously in both directions.

The association is real. In a Danish nationwide cohort of 37,661 women hospitalised with endometriosis between 1977 and 2007, the risk of later developing IBD was raised: a standardised incidence ratio of 1.5 overall, 1.6 for Crohn's disease specifically, and still 1.8 for Crohn's more than twenty years after the endometriosis diagnosis. Restricting to surgically verified endometriosis strengthened the associations (Jess 2012). The authors were careful to note that the association could reflect shared immunological features, or an effect of oral contraceptive treatment for endometriosis on IBD risk, rather than one condition causing the other. This was also a hospitalised endometriosis cohort, so the women in it had more severe disease than average.

And it may be badly underdetected in IBD clinics. In the Italian prospective study, 82 women with IBD who had at least one endometriosis-compatible symptom underwent transvaginal ultrasound. Endometriosis was found in 62.2%, and in 86.3% of those it was deep infiltrating endometriosis. On multivariate analysis, two symptoms predicted it: pain during deep sex (odds ratio 4.7, 95% CI 1.6 to 13.9) and heavy menstrual bleeding (odds ratio 4.3, 95% CI 1.4 to 12.9) (Neri 2026).

Endometriosis is also diagnosed slowly. A Dutch study of 837 women with confirmed endometriosis found a median total diagnostic delay of seven years, with the longest delays in those presenting with painful periods or bleeding problems (de Kok 2026). A French e-cohort of 6,949 participants found an average delay of ten years for endometriosis and eleven for adenomyosis, and notably found that a higher number of comorbidities was associated with a longer delay (Breton 2026). If you have Crohn's, you are a person with a comorbidity, and that finding is about you.

So the symptoms worth raising specifically with a GP or gynaecologist, not only with your gastroenterologist:

• Period pain severe enough to stop you doing normal things, especially if it has got worse over years.
• Pain deep inside during or after sex.
• Heavy menstrual bleeding.
• Pain on opening your bowels that is worse around your period.
• Cyclical rectal bleeding that recurs at the same point every month.
• Difficulty getting pregnant alongside any of the above.

These should be raised even if your Crohn's is active, and arguably especially then, because that is when they are most likely to be attributed elsewhere. Our post on getting a doctor to take gut symptoms seriously covers escalation routes when a symptom keeps being explained away, and most of it transfers directly.

Does Crohn's change your periods, rather than the other way round?

Yes, and this direction gets even less attention.

In a prospective registry study of 121 women enrolled within six months of their IBD diagnosis and followed for at least two years, 25% experienced a change in cycle interval in the year before diagnosis and 21% a change in the duration of flow. Among women with painful periods, 40% experienced a change in the intensity of that pain and 31% in its duration. Overall cycle regularity increased over time after diagnosis, and quality of life was significantly lower at every time point in women without regular cycles (Saha 2014).

That last finding is the useful one. The disruption clusters around the sickest stretch, the year before diagnosis when the disease was active and untreated, and settles as things are brought under control. Several people in the Crohn's threads described their periods stopping entirely when they were at their most unwell, then returning as they improved.

A narrative review of menstrual abnormalities in IBD reaches broadly the same conclusion, that IBD has been associated with delayed menarche and with irregularities in cycle length and flow, and also raises the separate question of how biological therapies interact with gynaecological conditions (Malinauskiene 2023). We are flagging that review as a review rather than as primary evidence, and it does not establish a causal effect of any particular drug on your cycle.

The related territory of sexual function is also worth naming, because dyspareunia turned out to be the strongest endometriosis predictor above and people rarely volunteer it. A cross-sectional survey of 83 women with IBD and 340 controls at a Vienna centre assessed sexual function and attitudes to contraception using a validated index and a self-designed questionnaire (Mayrhofer 2025). We are citing it for the fact that this is being studied and that contraception attitudes in IBD are a recognised research question, not for a specific effect size, since we read the abstract rather than the full results.

Contraception: what people actually do, and what the evidence says

Read any Crohn's period thread and the same workaround appears within five comments: using continuous hormonal contraception, an IUD, or an implant to stop having periods at all. It is described repeatedly as the single most effective thing people have done about monthly worsening.

That is lived experience, and it is worth knowing that the practice is widespread. It is not evidence that it changes Crohn's disease activity, and we could not find a trial testing it. Here is what the research does say, and it points in more than one direction.

On oral contraceptives and Crohn's outcomes. In a Swedish national study of 4,036 women with Crohn's disease, current oral contraceptive use was not significantly associated with Crohn's-related surgery on its own (multivariable-adjusted hazard ratio 1.30, 95% CI 0.89 to 1.92). However, the risk of surgery increased with longer duration of use (P for trend 0.036) and with higher prescribed daily dose (P for trend 0.016) (Khalili 2016, Gastroenterology).

On oral contraceptives and ulcerative colitis outcomes. The equivalent study in 6,104 women with ulcerative colitis found neither current nor past use significantly associated with UC-related surgery, and no modification by type of preparation (Khalili 2016, American Journal of Gastroenterology).

Both are observational national register studies. They cannot establish cause, and women prescribed contraceptives for longer at higher doses may differ from other women in ways the models did not capture. But the Crohn's signal is a dose-and-duration trend, which is the pattern you would expect if something real were going on, and it is specific to Crohn's rather than to IBD generally.

One thing worth separating out: if heavy menstrual bleeding is the actual problem, that is a treatable problem in its own right with its own assessment pathway, and it is a reason to see a GP or gynaecologist rather than to manage it through your gastroenterologist. Heavy bleeding plus Crohn's-related iron loss is a combination where fixing either side helps.

Perimenopause and menopause

People ask this one nervously, often in their late thirties, and the Crohn's threads are full of women in their forties saying their symptoms and their cycle both went unpredictable at once.

The research here is thin, retrospective and small, and we are going to say so rather than dress it up.

• Menopause may come slightly earlier. In a retrospective cohort using the Rochester Epidemiology Project, 83 women with IBD and 88 without, the mean age at menopause was 50.0 years in the IBD group versus 51.5 years in controls (P = .006). The authors themselves noted it is unclear whether a 1.5 year difference is clinically relevant, and the IBD group contained more former and current smokers, which is a known influence on menopausal age (Moktan 2022).
• Hormone replacement therapy has been associated with better disease activity after menopause, twice, retrospectively. In a retrospective study of 65 women followed at a Chicago IBD clinic, 45 of them with Crohn's, postmenopausal hormone replacement showed a significant protective effect on disease activity (Kane 2008). A later multicentre retrospective case-control study found hormone replacement associated with a 5.6-fold increase in the odds of improvement in physician global assessment score compared with controls (OR 5.6, 95% CI 1.6 to 19.7) (Freeman 2023). Physician global assessment is a clinician's impression, not an endoscopic or biomarker measure, and both studies were retrospective with no randomisation.
• Hormone replacement does not appear to change whether you develop IBD. A Taiwanese national claims cohort of 10,126 postmenopausal women found adjusted hazard ratios of 1.33 (95% CI 0.46 to 3.83) for ulcerative colitis and 0.72 (95% CI 0.45 to 1.16) for Crohn's disease in hormone replacement users, neither statistically significant (Tseng 2025). That is a different question from disease course in people who already have IBD.

There are no randomised trials of hormone therapy for disease activity in IBD. What you can reasonably take from this is that "my Crohn's got weird in perimenopause" is a plausible and commonly described experience, that it is not well studied, and that it is a legitimate thing to raise with both your IBD team and whoever manages your menopause care rather than something to absorb silently.

A worked example: three cycles, one conversation

Tracking only earns its keep if it answers a question. Here is the question worth answering: does my worsening start and stop with my bleeding, or does it keep climbing?

That is a two-variable problem, and you need roughly three cycles of data for it to mean anything. Here is what one person's log might look like at the point it becomes useful.

Cycles one and two show the pattern that fits a hormonal symptom effect: a sharp rise, a peak on the heaviest bleeding days, and a return to your own baseline within a few days of the period ending. Cycle three does not. The blood has changed character, the stool frequency has not come back down, and the timeline has decoupled from the bleeding. That is the point at which "it is my period" stops being a sufficient explanation, and it is visible in three lines of a table rather than in a feeling.

Two things make this log work that people usually get wrong. First, it records the cycle day, not just the date, so the two variables can be compared at all. Second, it records your own baseline days as well as your bad ones, because "worse" is meaningless without a "normal" to measure it against. Our guide to interpreting a Harvey-Bradshaw Index score explains why a score taken on day two of your period is not comparable with one taken mid-cycle, and why the stool count item can swallow the whole score.

If you would rather not keep this on paper, Clairop is built for logging symptoms alongside the things that might be driving them, and the resulting record is easier to hand over than a three-month verbal summary. No app, this one included, can tell you whether you are inflamed. Only a test can do that.

What to say to your IBD team

Kane's 1998 paper ended with a line that is still the best clinical summary of this topic: the physiological and clinical effects of the menstrual cycle should be taken into consideration when assessing for disease activity (Kane 1998). Nearly thirty years later, plenty of clinic appointments still do not do that, and the Crohn's threads are full of people saying their gastroenterologist has never raised it.

So raise it yourself, and raise it as a specific question rather than a complaint:

1. "My symptoms rise in the four days around my period and settle within three days of it ending. Is that worth investigating, or is that the expected pattern?" This gives your clinician the shape, not just the volume.
2. "Does the cycle day affect how you read my CRP or my Harvey-Bradshaw score?" Most people never ask, and it opens the door to timing future tests consistently.
3. "What should I use for period pain, given my Crohn's?" Ask in a routine appointment, before you need it.
4. "My periods are heavy. Can we check iron studies, not just haemoglobin?"
5. "I have pain during sex and severe period pain. Who should I see about endometriosis?" Say it even if it feels like the wrong clinic. Especially then.

Bringing three cycles of logged data to that conversation changes it from a description into a pattern. It is also worth knowing that this works better in a planned appointment than in a flare call. Our post on preparing for a GI appointment covers the one-page summary format that survives a short slot, and if you have a colonoscopy coming up, prep with Crohn's has the questions to ask in advance.

Myths worth retiring

"It's just hormones." This is an explanation, not a diagnosis, and it has never ruled anything out. It becomes actively dangerous when it is used to explain away bleeding that changed character, pain that did not settle, or a symptom pattern that has drifted off your cycle.

"Over half of women with IBD flare during their period." This misreads Rolston 2018. Over half reported worsening symptoms on a five-point self-report scale in an online survey. Nobody measured a flare. The two studies that measured something objective found no cycle effect on IBD activity.

"Birth control will sort your Crohn's out." No trial has tested this. The community experience of skipping periods is real and widely reported, and it is about symptom exposure, not disease control. The observational data on long-term oral contraceptive use in Crohn's shows a dose and duration trend towards more surgery, not less (Khalili 2016).

"Ibuprofen is fine, it is only two days a month." Maybe, and it is not a decision to make from a search result. The studies above found relapse within nine days of starting non-selective NSAIDs in quiescent IBD and a higher risk of active Crohn's at frequent use (Takeuchi 2006, Long 2016). Ask your team.

"You can't have endometriosis, you've got Crohn's." Having one condition is not protective against another, and the register data points the other way. Women with a comorbidity waited longer for an endometriosis diagnosis, not less long (Breton 2026).

"If your period stopped, your Crohn's must be under control." The opposite is more often true. Cycle disruption clusters in the year before diagnosis, when disease is active (Saha 2014).

"Track it and it will get better." Tracking does not treat anything, and we are not going to claim otherwise. What it does is let you and your clinician tell one explanation from another, which is a different and more modest kind of useful.

When to see a doctor promptly

Contact your IBD team, GP or out-of-hours service promptly if you notice:

• New, heavier or unexplained rectal bleeding, or blood mixed through the stool rather than sitting separately.
• Symptoms that do not settle within a few days of your period ending, or a monthly pattern that has changed shape.
• Unintentional weight loss.
• Fever, or feeling generally unwell with your gut symptoms.
• Bowel movements waking you at night.
• New or worsening fatigue, breathlessness or dizziness, which may point to anaemia.
• Periods that stop, become much heavier, or change markedly.
• Pain during deep sex, or pain on opening your bowels that is worse around your period.

Seek urgent, same-day medical care if you have:

• Severe colicky abdominal pain with vomiting, distension and no stool or wind passing, which can mean a bowel obstruction.
• Dark, tarry or black stool.
• Heavy bleeding with faintness, a racing heart or breathlessness.
• A high fever with severe abdominal pain.

None of these become less urgent because it is the week of your period. If anything, the risk is the opposite: a plausible monthly explanation is exactly what lets a genuine change go unreported for another few weeks.

The honest bottom line

Your period is very likely making your Crohn's symptoms worse, and the research backs you up on that. Women with Crohn's report more diarrhoea and more abdominal pain around menstruation than women without it, consistently, across decades and across countries.

What the research does not show is your period driving your Crohn's inflammation. The prospective diary study found general gut symptoms moving while IBD-specific symptoms did not, and the endoscopy study found menstrual distress tracking quality of life rather than disease severity. Nobody has measured faecal calprotectin across the cycle in IBD at all.

That combination means three practical things. Symptoms that rise and fall cleanly with your bleeding days are, on the current evidence, most likely a symptom-load effect on a gut with less reserve, and worth planning around rather than panicking about. Symptoms that keep climbing after your period ends have stopped fitting that explanation and deserve a phone call. And the two conditions most likely to be sitting underneath a monthly pattern that never quite resolves, iron deficiency and endometriosis, are both things you have to name out loud to get looked for, because a Crohn's diagnosis on your file will otherwise absorb every symptom you bring.

The cheapest version of all of this is one extra column in whatever you already use to track your symptoms: the day of your cycle. Three months of that turns "my Crohn's is worse on my period" from something you have to argue for into something you can show.